New Insights on Signaling Pathways Deregulated in LAP1-Deficient Cells: A Proteomics Study

Mutations in genes encoding nuclear envelope (NE) proteins, despite being rare, represent a major threat to cell homeostasis by compromising nuclear integrity and function as well as nucleocytoplasmic communication. In the last decade, several diseases have been associated to mutations in the <i&...

Full description

Bibliographic Details
Main Authors: Cátia D. Pereira, Guadalupe Espadas, Filipa Martins, Anne T. Bertrand, Laurent Servais, Eduard Sabidó, Odete A. B. da Cruz e Silva, Sandra Rebelo
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Biology and Life Sciences Forum
Subjects:
Online Access:https://www.mdpi.com/2673-9976/21/1/25
_version_ 1797595744246431744
author Cátia D. Pereira
Guadalupe Espadas
Filipa Martins
Anne T. Bertrand
Laurent Servais
Eduard Sabidó
Odete A. B. da Cruz e Silva
Sandra Rebelo
author_facet Cátia D. Pereira
Guadalupe Espadas
Filipa Martins
Anne T. Bertrand
Laurent Servais
Eduard Sabidó
Odete A. B. da Cruz e Silva
Sandra Rebelo
author_sort Cátia D. Pereira
collection DOAJ
description Mutations in genes encoding nuclear envelope (NE) proteins, despite being rare, represent a major threat to cell homeostasis by compromising nuclear integrity and function as well as nucleocytoplasmic communication. In the last decade, several diseases have been associated to mutations in the <i>TOR1AIP1</i> gene that codes for lamina-associated polypeptide 1 (LAP1), a NE protein ubiquitously expressed in human tissues. Although this is suggestive of an important physiological role of LAP1, it remains unclear which cellular activities are regulated by this protein. To address this, we investigated the molecular repercussions of its deficiency in patient-derived skin fibroblasts carrying a pathological LAP1 mutation (p.E482A), previously reported in a case of severe dystonia, cerebellar atrophy and cardiomyopathy. Using liquid chromatography with tandem mass spectrometry (LC–MS/MS), a quantitative proteome analysis was performed to identify up-/downregulated proteins in LAP1 E482A fibroblasts relative to age-matched control fibroblasts. A subsequent functional characterization of the LC–MS/MS-identified differentially expressed proteins using bioinformatics tools unraveled various signaling pathways/biological processes potentially deregulated in LAP1 E482A fibroblasts, such as DNA repair, neurodevelopment and myogenesis, among others. This work sheds light on dysfunctional molecular mechanisms in LAP1-deficient cells, which will contribute to a better understanding of LAP1’s physiological relevance for the maintenance of cell homeostasis and, hopefully, allow the identification of potential therapeutic targets for LAP1-associated pathologies.
first_indexed 2024-03-11T02:41:43Z
format Article
id doaj.art-5b4cb43d62b44f87a0df988e825613f6
institution Directory Open Access Journal
issn 2673-9976
language English
last_indexed 2024-03-11T02:41:43Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Biology and Life Sciences Forum
spelling doaj.art-5b4cb43d62b44f87a0df988e825613f62023-11-18T09:34:11ZengMDPI AGBiology and Life Sciences Forum2673-99762023-03-012112510.3390/blsf2023021025New Insights on Signaling Pathways Deregulated in LAP1-Deficient Cells: A Proteomics StudyCátia D. Pereira0Guadalupe Espadas1Filipa Martins2Anne T. Bertrand3Laurent Servais4Eduard Sabidó5Odete A. B. da Cruz e Silva6Sandra Rebelo7Department of Medical Sciences, Institute of Biomedicine (iBiMED), University of Aveiro, 3810-193 Aveiro, PortugalCentre de Regulació Genòmica (CRG), Barcelona Institute of Science and Technology (BIST), 08003 Barcelona, SpainDepartment of Medical Sciences, Institute of Biomedicine (iBiMED), University of Aveiro, 3810-193 Aveiro, PortugalInstitut de Myologie, Center of Research in Myology, INSERM UMRS 974, Medicine Faculty—Sorbonne Université, 75013 Paris, FranceMDUK Oxford Neuromuscular Center, Department of Paediatrics, University of Oxford and NIHR Oxford Biomedical Research Center, Oxford OX3 9DU, UKCentre de Regulació Genòmica (CRG), Barcelona Institute of Science and Technology (BIST), 08003 Barcelona, SpainDepartment of Medical Sciences, Institute of Biomedicine (iBiMED), University of Aveiro, 3810-193 Aveiro, PortugalDepartment of Medical Sciences, Institute of Biomedicine (iBiMED), University of Aveiro, 3810-193 Aveiro, PortugalMutations in genes encoding nuclear envelope (NE) proteins, despite being rare, represent a major threat to cell homeostasis by compromising nuclear integrity and function as well as nucleocytoplasmic communication. In the last decade, several diseases have been associated to mutations in the <i>TOR1AIP1</i> gene that codes for lamina-associated polypeptide 1 (LAP1), a NE protein ubiquitously expressed in human tissues. Although this is suggestive of an important physiological role of LAP1, it remains unclear which cellular activities are regulated by this protein. To address this, we investigated the molecular repercussions of its deficiency in patient-derived skin fibroblasts carrying a pathological LAP1 mutation (p.E482A), previously reported in a case of severe dystonia, cerebellar atrophy and cardiomyopathy. Using liquid chromatography with tandem mass spectrometry (LC–MS/MS), a quantitative proteome analysis was performed to identify up-/downregulated proteins in LAP1 E482A fibroblasts relative to age-matched control fibroblasts. A subsequent functional characterization of the LC–MS/MS-identified differentially expressed proteins using bioinformatics tools unraveled various signaling pathways/biological processes potentially deregulated in LAP1 E482A fibroblasts, such as DNA repair, neurodevelopment and myogenesis, among others. This work sheds light on dysfunctional molecular mechanisms in LAP1-deficient cells, which will contribute to a better understanding of LAP1’s physiological relevance for the maintenance of cell homeostasis and, hopefully, allow the identification of potential therapeutic targets for LAP1-associated pathologies.https://www.mdpi.com/2673-9976/21/1/25LAP1DNA repairneurodevelopmentmyogenesis
spellingShingle Cátia D. Pereira
Guadalupe Espadas
Filipa Martins
Anne T. Bertrand
Laurent Servais
Eduard Sabidó
Odete A. B. da Cruz e Silva
Sandra Rebelo
New Insights on Signaling Pathways Deregulated in LAP1-Deficient Cells: A Proteomics Study
Biology and Life Sciences Forum
LAP1
DNA repair
neurodevelopment
myogenesis
title New Insights on Signaling Pathways Deregulated in LAP1-Deficient Cells: A Proteomics Study
title_full New Insights on Signaling Pathways Deregulated in LAP1-Deficient Cells: A Proteomics Study
title_fullStr New Insights on Signaling Pathways Deregulated in LAP1-Deficient Cells: A Proteomics Study
title_full_unstemmed New Insights on Signaling Pathways Deregulated in LAP1-Deficient Cells: A Proteomics Study
title_short New Insights on Signaling Pathways Deregulated in LAP1-Deficient Cells: A Proteomics Study
title_sort new insights on signaling pathways deregulated in lap1 deficient cells a proteomics study
topic LAP1
DNA repair
neurodevelopment
myogenesis
url https://www.mdpi.com/2673-9976/21/1/25
work_keys_str_mv AT catiadpereira newinsightsonsignalingpathwaysderegulatedinlap1deficientcellsaproteomicsstudy
AT guadalupeespadas newinsightsonsignalingpathwaysderegulatedinlap1deficientcellsaproteomicsstudy
AT filipamartins newinsightsonsignalingpathwaysderegulatedinlap1deficientcellsaproteomicsstudy
AT annetbertrand newinsightsonsignalingpathwaysderegulatedinlap1deficientcellsaproteomicsstudy
AT laurentservais newinsightsonsignalingpathwaysderegulatedinlap1deficientcellsaproteomicsstudy
AT eduardsabido newinsightsonsignalingpathwaysderegulatedinlap1deficientcellsaproteomicsstudy
AT odeteabdacruzesilva newinsightsonsignalingpathwaysderegulatedinlap1deficientcellsaproteomicsstudy
AT sandrarebelo newinsightsonsignalingpathwaysderegulatedinlap1deficientcellsaproteomicsstudy